{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:44:40Z","timestamp":1791873880967,"version":"4.3.4"},"reference-count":92,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Slovenian Research and Innovation Agency","award":["P3-0083"],"award-info":[{"award-number":["P3-0083"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>The complement system is a vital component of innate immunity. Besides its roles in pathogen defense, its significance in neurodevelopment, neurodegeneration, and cancer progression is beginning to be recognized. We performed a comprehensive literature review to summarize the involvement and dysregulation of the complement system in three main CNS-associated conditions: Alzheimer\u2019s disease, schizophrenia, and glioma. In Alzheimer\u2019s disease, activation of the complement system contributes to neuroinflammation, synaptic loss, and neuronal death. In glioblastoma, complement promotes tumor growth, immune evasion, and therapy resistance. In schizophrenia, genetic variations in complement components, particularly C4A, are associated with synaptic pruning abnormalities and disease susceptibility. We conclude that the complement system has a dual role of protector and pathogenic mediator in the central nervous system. While it is critical in neurodegenerative, oncological, and psychiatric disorders, its role is not understood well enough. For therapeutic purposes, targeting the complement system may open new frontiers for therapeutic interventions without disrupting important physiological processes. More research is needed to elucidate the exact roles of the complement and help translate these findings into clinical settings.<\/jats:p>","DOI":"10.3390\/biom15081179","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T07:53:12Z","timestamp":1755503592000},"page":"1179","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Complement Cascades and Brain Disorders"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0418-2986","authenticated-orcid":false,"given":"Ivana","family":"Jov\u010devska","sequence":"first","affiliation":[{"name":"Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1182-5417","authenticated-orcid":false,"given":"Alja","family":"Videti\u010d Paska","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1051-959X","authenticated-orcid":false,"given":"Katarina","family":"Kouter","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41577-023-00926-1","article-title":"A guide to complement biology, pathology and therapeutic opportunity","volume":"24","author":"Mastellos","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"ref_2","unstructured":"Ehrlich, P., and Morgenroth, J. (1899). Ueber haemolysine: Zweite mittheilung. Berliner Klinische Wochenschrift, Schumacher."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"J276","DOI":"10.1016\/j.jaut.2009.11.014","article-title":"The complement system in systemic autoimmune disease","volume":"34","author":"Chen","year":"2010","journal-title":"J. Autoimmun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41581-023-00766-1","article-title":"The role of complement in kidney disease","volume":"19","author":"Petr","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1172\/JCI90962","article-title":"The role of the complement system in cancer","volume":"127","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41582-020-0400-0","article-title":"Complement in neurological disorders and emerging complement-targeted therapeutics","volume":"16","author":"Dalakas","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"J168","DOI":"10.1016\/j.jaut.2009.11.018","article-title":"Defining and analyzing geoepidemiology and human autoimmunity","volume":"34","author":"Shapira","year":"2010","journal-title":"J. Autoimmun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","article-title":"An update on the global disparities in kidney disease burden and care across world countries and regions","volume":"12","author":"Bello","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"ref_9","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"23","author":"Steinmetz","year":"2024","journal-title":"Lancet Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1212\/WNL.0000000000205009","article-title":"Projected Global Burden of Brain Disorders Through 2050 (P7-15.001)","volume":"102","author":"Lei","year":"2024","journal-title":"Neurology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/ITT.S305420","article-title":"The Role of Complement in Synaptic Pruning and Neurodegeneration","volume":"10","author":"Acharya","year":"2021","journal-title":"Immunotargets Ther."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bohlson, S.S., Garred, P., Kemper, C., and Tenner, A.J. (2019). Complement Nomenclature-Deconvoluted. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01308"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41467-023-36068-0","article-title":"The classical pathway triggers pathogenic complement activation in membranous nephropathy","volume":"14","author":"Seifert","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Dob\u00f3, J., Kocsis, A., Farkas, B., Demeter, F., Cervenak, L., and G\u00e1l, P. (2024). The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031566"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nri800","article-title":"Evolution of the lectin\u2013complement pathway and its role in innate immunity","volume":"2","author":"Fujita","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2011.11.002","article-title":"Mannan-binding lectin deficiency\u2014Good news, bad news, doesn\u2019t matter?","volume":"143","author":"Heitzeneder","year":"2012","journal-title":"Clin. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/imr.13130","article-title":"Initiation of the alternative pathway of complement and the history of \u201ctickover\u201d","volume":"313","author":"Pangburn","year":"2023","journal-title":"Immunol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/imr.13155","article-title":"Factor D","volume":"313","author":"Sekine","year":"2023","journal-title":"Immunol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Merle, N.S., Church, S.E., Fremeaux-Bacchi, V., and Roumenina, L.T. (2015). Complement System Part I\u2014Molecular Mechanisms of Activation and Regulation. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00262"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Shah, A., Kishore, U., and Shastri, A. (2021). Complement System in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413647"},{"key":"ref_22","unstructured":"Abbott, J.D., Ball, G., Boumpas, D., Bridges, S.L., Chatham, W., Curtis, J., Daniel, C., Hughes, L.B., Kao, A.H., and Langford, C. (2004). Terminal complement complex. Rheumatology and Immunology Therapy, Springer."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ajpath.2020.02.006","article-title":"Complement Membrane Attack Complex: New Roles, Mechanisms of Action, and Therapeutic Targets","volume":"190","author":"Xie","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1093\/brain\/awz222","article-title":"Targeting the complement system in bacterial meningitis","volume":"142","author":"Koelman","year":"2019","journal-title":"Brain"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nrneph.2017.156","article-title":"The renaissance of complement therapeutics","volume":"14","author":"Ricklin","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.42671","article-title":"Complement","volume":"76","author":"Monach","year":"2024","journal-title":"Arthritis Rheumatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of Complement Activation and Regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nsmb.3427","article-title":"Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses","volume":"24","author":"Xue","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4049\/jimmunol.2300333","article-title":"Diverse Functions of C4b-Binding Protein in Health and Disease","volume":"211","author":"Werner","year":"2023","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cei.12952","article-title":"Production of complement components by cells of the immune system","volume":"188","author":"Lubbers","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/febs.15772","article-title":"Complement cascade functions during brain development and neurodegeneration","volume":"289","author":"Fatoba","year":"2022","journal-title":"FEBS J."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Chen, Y., Chu, J.M.T., Chang, R.C.C., and Wong, G.T.C. (2022). The Complement System in the Central Nervous System: From Neurodevelopment to Neurodegeneration. Biomolecules, 12.","DOI":"10.3390\/biom12020337"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Magdalon, J., Mansur, F., Teles e Silva, A.L., de Goes, V.A., Reiner, O., and Serti\u00e9, A.L. (2020). Complement System in Brain Architecture and Neurodevelopmental Disorders. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.00023"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tins.2018.03.009","article-title":"Complement: The Emerging Architect of the Developing Brain","volume":"41","author":"Coulthard","year":"2018","journal-title":"Trends Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.1073\/pnas.1722613115","article-title":"Local apoptotic-like mechanisms underlie complement-mediated synaptic pruning","volume":"115","author":"Kun","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev-immunol-101921-035639","article-title":"Complement in the Brain: Contributions to Neuroprotection, Neuronal Plasticity, and Neuroinflammation","volume":"41","author":"Bohlson","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.aaz2288","article-title":"Microglia mediate forgetting via complement-dependent synaptic elimination","volume":"367","author":"Wang","year":"2020","journal-title":"Science"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Yarmoska, S.K., Alawieh, A.M., Tomlinson, S., and Hoang, K.B. (2021). Modulation of the Complement System by Neoplastic Disease of the Central Nervous System. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.689435"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: A key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Ziabska, K., Ziemka-Nalecz, M., Pawelec, P., Sypecka, J., and Zalewska, T. (2021). Aberrant Complement System Activation in Neurological Disorders. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094675"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jneuroim.2014.11.016","article-title":"Complement activation in Glioblastoma multiforme pathophysiology: Evidence from serum levels and presence of complement activation products in tumor tissue","volume":"278","author":"Bouwens","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.imbio.2019.07.006","article-title":"Secretion of functionally active complement factor H related protein 5 (FHR5) by primary tumour cells derived from Glioblastoma Multiforme patients","volume":"224","author":"DeCordova","year":"2019","journal-title":"Immunobiology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.25172","article-title":"High complement levels in astrocyte-derived exosomes of Alzheimer disease","volume":"83","author":"Goetzl","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0169-328X(92)90017-6","article-title":"Complement gene expression in human brain: Comparison between normal and Alzheimer disease cases","volume":"14","author":"Walker","year":"1992","journal-title":"Mol. Brain Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00702-012-0797-8","article-title":"Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer\u2019s disease","volume":"119","author":"Daborg","year":"2012","journal-title":"J. Neural Transm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12035-014-8723-8","article-title":"CR1 in Alzheimer\u2019s Disease","volume":"51","author":"Zhu","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/YPG.0000000000000291","article-title":"Explore the role of CR1 genetic variants in late-onset Alzheimer\u2019s disease susceptibility","volume":"31","author":"Lu","year":"2021","journal-title":"Psychiatr. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Yuan, H., Du, L., and Ge, P. (2020). Complement receptor 1 genetic polymorphism contributes to sporadic Alzheimer\u2019s disease susceptibility in Caucasians: A meta-analysis. Biosci. Rep., 40.","DOI":"10.1042\/BSR20200321"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.schres.2014.07.053","article-title":"Maternal complement C1q and increased odds for psychosis in adult offspring","volume":"159","author":"Severance","year":"2014","journal-title":"Schizophr. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41537-023-00409-1","article-title":"Association of elevated levels of peripheral complement components with cortical thinning and impaired logical memory in drug-na\u00efve patients with first-episode schizophrenia","volume":"9","author":"Yu","year":"2023","journal-title":"Schizophrenia"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Ah-Pine, F., Malaterre-Septembre, A., Bedoui, Y., Khettab, M., Neal, J.W., Freppel, S., and Gasque, P. (2023). Complement Activation and Up-Regulated Expression of Anaphylatoxin C3a\/C3aR in Glioblastoma: Deciphering the Links with TGF-beta and VEGF. Cancers, 15.","DOI":"10.3390\/cancers15092647"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e742","DOI":"10.1016\/j.wneu.2023.06.133","article-title":"Complement Components in Peripheral Blood from Adult Patients with IDH Wild-Type Glioblastoma","volume":"177","author":"Jonsson","year":"2023","journal-title":"World Neurosurg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Andrade-Guerrero, J., Santiago-Balmaseda, A., Jeronimo-Aguilar, P., Vargas-Rodr\u00edguez, I., Cadena-Su\u00e1rez, A.R., S\u00e1nchez-Garibay, C., Pozo-Molina, G., M\u00e9ndez-Catal\u00e1, C.F., Cardenas-Aguayo, M.D., and Diaz-Cintra, S. (2023). Alzheimer\u2019s Disease: An Updated Overview of Its Genetics. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043754"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Nikolac Perkovic, M., Videtic Paska, A., Konjevod, M., Kouter, K., Svob Strac, D., Nedic Erjavec, G., and Pivac, N. (2021). Epigenetics of Alzheimer\u2019s Disease. Biomolecules, 11.","DOI":"10.3390\/biom11020195"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Carapeto, A.P., Marcuello, C., Fa\u00edsca, P.F.N., and Rodrigues, M.S. (2024). Morphological and Biophysical Study of S100A9 Protein Fibrils by Atomic Force Microscopy Imaging and Nanomechanical Analysis. Biomolecules, 14.","DOI":"10.3390\/biom14091091"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Ziaunys, M., Sakalauskas, A., Mikalauskaite, K., and Smirnovas, V. (2021). Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212382"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","article-title":"Complement activation by beta-amyloid in Alzheimer disease","volume":"89","author":"Rogers","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2174\/1567205013666160129095924","article-title":"Glial Cells\u2014The Key Elements of Alzheimer\u00b4s Disease","volume":"13","author":"Dzamba","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","article-title":"Schizophrenia","volume":"399","author":"Jauhar","year":"2022","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"American Psychiatric Publishing (2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Publishing. [5th ed.].","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biopsych.2014.05.023","article-title":"Progressive reduction in cortical thickness as psychosis develops: A multisite longitudinal neuroimaging study of youth at elevated clinical risk","volume":"77","author":"Cannon","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","article-title":"Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia","volume":"57","author":"Glantz","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archpsyc.60.12.1187","article-title":"Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies","volume":"60","author":"Sullivan","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1096-8628(200021)97:1<18::AID-AJMG4>3.0.CO;2-L","article-title":"Adoption studies of schizophrenia","volume":"97","author":"Ingraham","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511, 421\u2013427.","DOI":"10.1038\/nature13595"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"Purcell","year":"2009","journal-title":"Nature"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.schres.2018.01.018","article-title":"C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis","volume":"197","author":"Melbourne","year":"2018","journal-title":"Schizophr. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"577793","DOI":"10.1016\/j.jneuroim.2021.577793","article-title":"Relationship of selective complement markers with schizophrenia","volume":"363","author":"Asyraf","year":"2022","journal-title":"J. Neuroimmunol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Mayilyan, K.R., Krarup, A., Soghoyan, A.F., Jensenius, J.C., and Sim, R.B. (2023). l-ficolin-MASP arm of the complement system in schizophrenia. Immunobiology, 228.","DOI":"10.1016\/j.imbio.2023.152349"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"46","DOI":"10.12703\/P6-46","article-title":"Advances in treating glioblastoma","volume":"6","author":"Weathers","year":"2014","journal-title":"F1000Prime Rep."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Fornvik, K., Maddahi, A., Persson, O., Osther, K., Salford, L.G., and Nittby Redebrandt, H. (2017). C1-inactivator is upregulated in glioblastoma. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183086"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2006.03.003","article-title":"Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain","volume":"9","author":"Sun","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/neuonc\/noaa064","article-title":"Crosstalk between GBM cells and mesenchymal stemlike cells promotes the invasiveness of GBM through the C5a\/p38\/ZEB1 axis","volume":"22","author":"Lim","year":"2020","journal-title":"Neuro-Oncology"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Zhu, H., Yu, X., Zhang, S., and Shu, K. (2021). Targeting the Complement Pathway in Malignant Glioma Microenvironments. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.657472"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/10408363.2021.1907297","article-title":"Complement testing in the clinical laboratory","volume":"58","author":"Willrich","year":"2021","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1309\/AJCPXPD7ZQXNTIAL","article-title":"Effect of Blood Sampling, Processing, and Storage on the Measurement of Complement Activation Biomarkers","volume":"143","author":"Yang","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00277-022-04903-x","article-title":"Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria","volume":"101","author":"Wong","year":"2022","journal-title":"Ann. Hematol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00281-021-00892-7","article-title":"Tipping the balance: Intricate roles of the complement system in disease and therapy","volume":"43","author":"Pouw","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jinf.2019.11.015","article-title":"Antibiotic prophylaxis in vaccinated eculizumab recipients who developed meningococcal disease","volume":"80","author":"Crew","year":"2020","journal-title":"J. Infect."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41582-024-01014-1","article-title":"NMOSD and MOGAD: An evolving disease spectrum","volume":"20","author":"Uzawa","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.tips.2022.02.006","article-title":"Targeting complement in neurodegeneration: Challenges, risks, and strategies","volume":"43","author":"Zelek","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/09727531231189925","article-title":"Lecanemab: A Hopeful Alzheimer\u2019s Disease Treatment","volume":"31","author":"Mughal","year":"2024","journal-title":"Ann. Neurosci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40478-022-01416-6","article-title":"C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer\u2019s disease","volume":"10","author":"Carvalho","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/BTT.S394843","article-title":"Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis","volume":"17","author":"Popov","year":"2023","journal-title":"Biol. Targets Ther."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Liljedahl, E., Konradsson, E., Gustafsson, E., Jonsson, K.F., Olofsson, J.K., Osther, K., Ceberg, C., and Redebrandt, H.N. (2023). Combined anti-C1-INH and radiotherapy against glioblastoma. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-10583-1"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Hettmann, T., Gillies, S.D., Kleinschmidt, M., Piechotta, A., Makioka, K., Lemere, C.A., Schilling, S., Rahfeld, J.U., and Lues, I. (2020). Development of the clinical candidate PBD-C06, a humanized pGlu3-A\u03b2-specific antibody against Alzheimer\u2019s disease with reduced complement activation. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-60319-5"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/brain\/awad341","article-title":"Extracellular vesicle biomarkers for complement dysfunction in schizophrenia","volume":"147","author":"Xue","year":"2023","journal-title":"Brain"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis","volume":"155","author":"Upthegrove","year":"2014","journal-title":"Schizophr. Res."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/8\/1179\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:29:16Z","timestamp":1760034556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/8\/1179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,17]]},"references-count":92,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["biom15081179"],"URL":"https:\/\/doi.org\/10.3390\/biom15081179","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,17]]}}}